Procter & Gamble, Johnson & Johnson, and Coca-Cola are set to reach target prices of $180, $300, and $100 respectively by 2027, driven by their strong dividend histories and growth catalysts. PG aims for $180 supported by productivity gains and steady revenue growth, JNJ targets $300 fueled by a robust oncology pipeline and strategic spin-offs, while KO expects $100 boosted by global campaigns like the 2026 FIFA World Cup and rising organic growth. These defensive stocks benefit from recession-level consumer sentiment and increased spending on healthcare and staples, making them durable investments with potential returns of 15-22% by 2027.
L Catterton, a leading consumer investment firm, has agreed to sell Thorne, a science-backed wellness brand, to Procter & Gamble for $3.8 billion in cash. Since investing in Thorne in 2023, L Catterton accelerated its growth by enhancing leadership, ...
Procter & Gamble (P&G) has agreed to acquire Thorne, a leader in science-backed health and wellness solutions, to strengthen its position in the premium wellness market. Thorne, trusted by healthcare practitioners and consumers since 1984, offers hig...
